Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

v3.22.4
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total Shareholders Equity [Member]
Noncontrolling Interest [Member]
Total
Balance, value at Oct. 31, 2021 $ 301 $ 239,927 $ (204,790) $ 35,438 $ (671) $ 34,767
Balance, shares at Oct. 31, 2021 30,050,894          
Stock option compensation to employees and directors 2,135 2,135 2,135
Stock options and warrants issued to consultants 219 219 219
Common stock issued upon exercise of stock options and warrants
Common stock issued upon exercise of stock options, shares 81,425          
Net loss (3,829) (3,829) (50) (3,879)
Balance, value at Jan. 31, 2022 $ 301 242,281 (208,619) 33,963 (721) 33,242
Balance, shares at Jan. 31, 2022 30,132,319          
Balance, value at Oct. 31, 2022 $ 309 247,123 (218,385) 29,047 (847) 28,200
Balance, shares at Oct. 31, 2022 30,913,902          
Stock option compensation to employees and directors 957 957 957
Stock options and warrants issued to consultants 81 81 81
Common stock issued to consultants 25 25 25
Common stock issued to consultants, shares 7,364          
Common stock issued upon exercise of stock options and warrants 3 3 3
Common stock issued upon exercise of stock options, shares 1,564          
Net loss (2,322) (2,322) (32) (2,354)
Balance, value at Jan. 31, 2023 $ 309 $ 248,189 $ (220,707) $ 27,791 $ (879) $ 26,912
Balance, shares at Jan. 31, 2023 30,922,830